| Time [Central European Time (CET) GMT +2] | Session | Speaker |
|---|---|---|
| Day 1 – Tuesday, October 13 (online) The global TB reality in 2026: Progress, pressure and the access gap |
||
| Block 1: The global TB picture – progress, pressure and what remains off track |
||
| 9:00–9:10 | Welcome and introduction | Chair: Prof. Onn Min Kon, Consultant Respiratory Physician, Imperial College London, England |
| 9:10–9:40 | Global tuberculosis 2026 – burden, progress, challenges and political reality |
Prof. Mario Raviglione, Professor of Global Health, University of Milan, Italy |
| 9:40–10:10 | Getting back on track: The critical actions needed to bend the TB curve by 2030 |
Prof. Soumya Swaminathan, M. S. Swaminathan Research Foundation, India |
| 10:10–10:20 | Break | |
| Block 2: Finding people earlier – populations, screening and prevention pathways |
||
| 10:20–10:50 | TB screening in patients under biologic treatment | Prof. Raquel Duarte, Pulmonologist and Professor of Epidemiology and Public Health, ICBAS, University of Porto, Portugal |
| 10:50–11:20 | TB and HIV | Prof. Graeme Meintjes, Infectious Diseases Clinician and Researcher, University of Cape Town, South Africa |
| 11:20–11:30 | Break | |
| Block 3: From TB infection to prevention – innovations that can scale |
||
| 11:30–12:00 | Genomic advances towards precision epidemiology and personalized medicine in tuberculosis |
Prof. Iñaki Comas, Principal Investigator, Tuberculosis Genomics Unit, Biomedicine Institute of Valencia – Spanish National Research Council CSIC, Spain |
| 12:00–12:30 | Drug-resistant TB and personalized TB therapy – what the next decade will require |
Prof. Annelies Van Rie, Physician-scientist, Epidemiologist and Public Health Specialist, University of Antwerp, Belgium |
| 12:30–12:40 | Conclusion and close – Day 1 | |
| Day 2 – Wednesday, October 14 (online) The regional TB picture: Expanding screening, improving testing and accelerating diagnosis |
||
| Block 1: APEC – regional topics |
||
| 9:00–9:10 | Welcome and introduction | Chair: Prof. Onn Min Kon, Consultant Respiratory Physician, Imperial College London, England Regional co-chair: Prof. Anthony Byrne, Thoracic Physician and Global Health Researcher, St Vincent’s Hospital, Sydney, Australia; Chair, NSW TB Advisory Committee and Respiratory Infections Group, TSANZ |
| 9:10–9:40 | Tuberculosis among foreign-born persons and latent tuberculosis infection in Japan: Insights from time since entry and age-related differences in imaging findings suggestive of prior tuberculosis |
Dr. Jin Takasaki, Chief Physician, Division of Respiratory Medicine, Japan Institute for Health Security (JIHS), Tokyo, Japan |
| 9:40–10:10 | Tuberculosis infection screening and management in patients with rheumatic diseases |
Prof. Mu Rong, Chief Physician and Director, Department of Rheumatology and Immunology, Peking University Third Hospital, China |
| 10:10–10:40 | Enhancing TB prevention strategies: The role of CD8+ immune responses in high-risk population screening |
Dr. Siti Hafsah, Senior Principal Assistant Director, Disease Control Division, Ministry of Health Malaysia, Malaysia |
| 10:40–10:50 | Break | |
| 10:50–11:30 | Effect of diabetes and chronic kidney disease on TB treatment |
Prof. Jinsoo Min, Pulmonologist, Seoul St. Mary’s Hospital, South Korea |
| 11:30–12:00 | TB YOUTH: Scaling up LTBI screening and exploring ultra-short 1H3P3 TPT among school TB close contacts in China |
Dr. Ruan Qiaoling, Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China |
| 12:00–12:30 | TB and comorbidities | Dr. Shamim Mannan, Director, Infectious Diseases, William J. Clinton Foundation, India |
| &12:30–12:40 | Conclusion and close – APEC | |
| Block 2: LATAM – regional topics |
||
| 16:00–16:10 | Welcome and introduction | Chair: Prof. Onn Min Kon, Consultant Respiratory Physician, Imperial College London, England |
| 16:10–16:40 | Understanding tuberculosis immunopathology through neutrophil and monocyte immune signatures |
Prof. Fabiani Gai Frantz, Principal Investigator, Laboratory of Immunology and Epigenetics of FCFRP, Ribeirao Preto, Brazil |
| 16:40–17:10 | Advancing TB elimination: The role of early TB infection detection in migrant health |
Dr. Joaquin Cervantes, Southwest University at El Paso, USA |
| 17:10–17:40 | Tuberculosis transmission dynamics in prison settings |
Dr. Gladys Estigarribia, Universidad Nacional de Caaguazú, Coronel Oviedo, Paraguay |
| 17:40–18:00 | Break and conclusion – LATAM | |
| Block 3: North America – regional topics |
||
| 18:00–18:05 | Welcome and introduction | Chair: Prof. Onn Min Kon, Consultant Respiratory Physician, Imperial College London, England Regional co-chair: Dr. Masae Kawamura, TB Clinician and Public Health Expert, USA |
| 18:05–18:10 | Voices to action: Building a TB-free Canada | Petra Heitkamp, Co-Chair, Stop TB Canada; Member, WHO PPM Core Group; Community Manager, TBPPM Learning Network Tina Campbell, Co-Chair, Stop TB Canada; Registered Nurse; TB Advisor, Northern Inter-Tribal Health Authority (NITHA), Canada |
| 18:10–18:40 | Associations between QuantiFERON-TB Gold Plus IFNγ concentrations and progression to symptomatic tuberculosis in global high-burden TB settings |
Dr. Justine Sunshine, Gates Medical Research Institute, Massachusetts, USA |
| 18:40–19:10 | There’s nothing latent about latent TB | Dr. David M. Lewinsohn, Pulmonologist, Oregon Health & Science University, Portland, Oregon, USA |
| 19:10–19:40 | TBD | TBD |
| 19:40–20:10 | The role of IGRA in tuberculosis screening in vulnerable populations: special considerations for kidney dialysis, biologic therapy, immunocompromised and elderly patients |
Dr. Muhammad Morshed, Clinical Professor, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada |
| 20:10–20:20 | Conclusion and close – North America | |
| Day 3 – Thursday, October 15 (online) Special populations and equity: Who is still being missed? |
||
| Block: Special populations and equity – who is still being missed? |
||
| 9:00–9:15 | Welcome and introduction | Chair: Prof. Onn Min Kon, Consultant Respiratory Physician, Imperial College London, England |
| 9:15–9:45 | Screening for TB infection in miners (TB and silicosis/occupational exposure) |
Dr. Patrick Howlett, MRC PhD Clinical Research Fellow, National Heart and Lung Institute, Imperial College London, England |
| 9:45–10:15 | Integrating TB and tobacco: Overcoming the barriers and missed opportunities |
Dr. Jagdish Kaur, Regional Adviser, Tobacco Free Initiative, WHO Regional Office for South-East Asia, India |
| 10:15–11:00 | Round table: TB at risk – the global consequences of funding cuts and the future of tuberculosis control |
Chair/moderator: Prof. Onn Min Kon, Imperial College London, England Panel: Prof. Keertan Dheda, University of Cape Town, South Africa; Dr. Suvanand Sahu, Stop TB Partnership, Geneva; Lord Nick Herbert, Global TB Caucus, England; Prof. Giovanni Migliori, IRCCS, Italy; Prof. Jonathan Stillo, Stop TB US, USA |
| 11:00–11:10 | Break | |
| 11:10–12:50 | Poster oral presentations | |
| 12:50–13:00 | Conclusion and close – Day 3 | |
| Day 4 – Friday, October 16 (online and on-site in London at the Royal College of Physicians) Future readiness: Policy, innovation and what comes next |
||
| Block: Future readiness – policy, innovation and what comes next |
||
| 10:15–10:20 (9:15 BST) |
Welcome and introduction | Chair: Prof. Onn Min Kon, Consultant Respiratory Physician, Imperial College London, England |
| 10:20–10:50 | Update TB Action Plan England | Dr. Lauren Ahyow, Consultant in Communicable Disease Control, TB Prevention UKHSA, England Stephen Hindle, Infectious Diseases Programme Manager, Prevention and Long Term Conditions Team, Medical Directorate, NHS England, England |
| 10:50–11:20 | Enhancing equity of access to TB services across the care cascade |
Prof. Tom Wingfield, Reader in Tuberculosis and Social Medicine and Deputy Director, LSTM Centre for TB Research, England |
| 11:20–11:50 | The hidden TB epidemic: What asymptomatic TB means for transmission and elimination |
Prof. Rein Houben, Professor of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom |
| 11:50–12:20 | Break | |
| 12:20–12:50 | Screening for latent TB in autoimmune patients | Prof. James Galloway, Deputy Head, Centre for Rheumatic Diseases, King’s College London, England |
| 12:50–13:20 | MDR TB | Dr. Lorenzo Guglielmetti, Infectious Diseases Physician and co-Principal Investigator, endTB and endTB-Q trials, Italy |
| 13:20–14:20 | Lunch | |
| 14:20–14:50 | Recent developments in child and adolescent tuberculosis |
Prof. James Seddon, Professor of Global Child Health, Imperial College London, England |
| 14:50–15:20 | TB meningitis | Prof. Guy Thwaites, Professor of Infectious Diseases, University of Oxford, England |
| 15:20–15:50 | Break | |
| 15:50–16:50 | Clinical TB cases Case 1 – When TB care meets infection control: Do we really need a negative-pressure room? Case 2 – Urban zoonotic tuberculosis Case 3 – Talk title TBD |
Case 1 – Dr. Moerida Belton, Consultant Respiratory Physician, Whittington Health NHS Trust, England Case 2 – Dr. Martin Dedicoat, Honorary Associate Clinical Professor, University Hospitals Birmingham Foundation Trust, England Case 3 – Dr. Heinke Kunst, Reader in Respiratory Medicine and Honorary Consultant in Respiratory Medicine, Queen Mary University of London, England |
| 16:50–17:00 | General Q&A and discussion | |
| 17:00–17:10 | Conclusion and close of the Global TB Clinical and Educational Summit 2026 |
Chair: Prof. Onn Min Kon, Consultant Respiratory Physician, Imperial College London, England |